Clinical trials
Gallbladder Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Jiao Tong University School of Medicine | 4 |
| Charite University, Berlin, Germany | 2 |
| Eastern Hepatobiliary Surgery Hospital | 2 |
| Fudan University | 2 |
| Peking Union Medical College Hospital | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| Yonsei University | 2 |
| Ajou University School of Medicine | 1 |
| Asan Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 40 |
| Cholangiocarcinoma | 14 |
| Pancreatic Neoplasms | 12 |
| Bile Duct Neoplasms | 7 |
| Biliary Tract Neoplasms | 7 |
| Carcinoma, Hepatocellular | 7 |
| Liver Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Esophageal Neoplasms | 4 |
| Colonic Neoplasms | 3 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.